Biotechnology Fund Class Fund Investor Sentiment

RYBOX Fund  USD 56.38  1.24  2.25%   
Slightly above 55% of Biotechnology Fund's investors are presently thinking to get in. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that some investors are interested at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
  
Biotechnology Fund stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Biotechnology earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Biotechnology Fund that are available to investors today. This information is accessible both publicly - through Biotechnology Fund's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biotechnology-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biotechnology Fund news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biotechnology Fund relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biotechnology Fund's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biotechnology Fund alpha.
over a year ago at news.google.com         
CA Rapid Response fund not rapid for flood victims - CalMatters
Google News at Macroaxis
a minute ago at finance.yahoo.com         
REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients...
Yahoo News
3 days ago at news.google.com         
Nektar Therapeutics Stock Analysis and Forecast - Tremendous financial leverage - jammulinksnews.com
Google News at Macroaxis
over a week ago at thefly.com         
Nektar call volume above normal and directionally bullish NKTR
news
over a week ago at news.google.com         
Why Nektar Therapeutics Stock Dived by 3 percent Today - AOL.com
Google News at Macroaxis
over two weeks ago at thefly.com         
Nektar price target raised by 25 at B. Riley NKTR
news
over two weeks ago at finance.yahoo.com         
Why Nektar Therapeutics Stock Dived by 3 percent Today
Yahoo News
over two weeks ago at benzinga.com         
MSC Industrial Direct, Constellation Brands And 3 Stocks To Watch Heading Into Tuesday
benzinga news
over two weeks ago at seekingalpha.com         
Nektar Therapeutics stock dips after pricing 100M stock offering
seekingalpha News
over two weeks ago at thefly.com         
Nektar 4.255M share Spot Secondary priced at 23.50 NKTR
news
over three weeks ago at seekingalpha.com         
Nektar Therapeutics launches proposed public offering
seekingalpha News
17 hours ago at gurufocus.com         
IQV UBS Raises Price Target on IQVIA Holdings to 225 IQV Stock News
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
IQVIA Earnings What To Look For From IQV
Yahoo News
3 days ago at thelincolnianonline.com         
Meridian Wealth Advisors LLC Boosts Stock Holdings in IQVIA Holdings Inc.
news
few days ago at simplywall.st         
At US159, Is It Time To Put IQVIA Holdings Inc. On Your Watch List?
Simply Wall St News at Macroaxis
few days ago at zacks.com         
Countdown to IQVIA Q2 Earnings A Look at Estimates Beyond Revenue and EPS
zacks News
six days ago at zacks.com         
Analysts Estimate Thermo Fisher Scientific to Report a Decline in Earnings What to Look Out for
zacks News
over a week ago at thelincolnianonline.com         
IQVIA Holdings Inc. Shares Sold by Stack Financial Management Inc
news
over a week ago at zacks.com         
Why IQVIA Holdings is a Top Growth Stock for the Long-Term
zacks News
over a week ago at insidermonkey.com         
IQVIA Unveils New Custom AI Agents with NVIDIA
insidermonkey News
over two weeks ago at finance.yahoo.com         
What to Expect From IQVIA Holdings Q2 2025 Earnings Report
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
a day ago at finance.yahoo.com         
Vertex Pharmaceuticals Outpaces Stock Market Gains What You Should Know
Yahoo News
few days ago at finance.yahoo.com         
Which Is the Best Magnificent Seven Stock to Buy Right Now?
Yahoo News
few days ago at finance.yahoo.com         
5 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
Yahoo News
few days ago at thelincolnianonline.com         
Bryn Mawr Capital Management LLC Acquires Shares of 456 Vertex Pharmaceuticals Incorporated
news
six days ago at zacks.com         
Vertex Pharmaceuticals Outpaces Stock Market Gains What You Should Know
zacks News
six days ago at pymnts.com         
Lloyds Bank Rolls Out Generative AI Tool Athena
news
six days ago at finance.yahoo.com         
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
Yahoo News
over a week ago at finance.yahoo.com         
Vertex Pharmaceuticals Declines More Than Market Some Information for Investors
Yahoo News
over a week ago at finance.yahoo.com         
Vertex Moves 5.0 percent Higher Will This Strength Last?
Yahoo News
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at finance.yahoo.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
Yahoo News
over a year ago at thelincolnianonline.com         
Baird Financial Group Inc. Has 5 Million Holdings in Seagen Inc.
news
a minute ago at finance.yahoo.com         
AGCO downgraded as Citi says riskreward now more balanced
Yahoo News
a day ago at thelincolnianonline.com         
Kingsview Wealth Management LLC Reduces Stock Holdings in Regeneron Pharmaceuticals, Inc.
news
2 days ago at finance.yahoo.com         
Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board Executive Leadership Tea...
Yahoo News
few days ago at thelincolnianonline.com         
Edgestream Partners L.P. Lowers Stock Position in Regeneron Pharmaceuticals, Inc.
news
few days ago at zacks.com         
Regeneron Stock Plunges 22.6 percent YTD Should You Buy, Sell or Hold?
zacks News
few days ago at thelincolnianonline.com         
Concord Wealth Partners Has 1.27 Million Stock Position in Regeneron Pharmaceuticals, Inc.
news
few days ago at deseret.com         
23andMe has officially been sold What will happen to customers data?
news
six days ago at finance.yahoo.com         
UBS Raises Regeneron Price Target, Maintains Neutral Rating
Yahoo News
over a week ago at finance.yahoo.com         
Hengrui, Kailera say dual-acting obesity shot succeeds in China study
Yahoo News
over a week ago at finance.yahoo.com         
Ascites Market Analysis and Forecasts Report 2025-2035 Market Surges Amid Rising Liver Disease and C...
Yahoo News
a minute ago at accesswire.com         
Class Action Filed Against Moderna, Inc. Seeking Recovery for Investors - Contact Levi Korsinsky
news
17 hours ago at benzinga.com         
Whats Going On With Moderna Stock Wednesday?
benzinga news
2 days ago at thelincolnianonline.com         
Moderna, Inc. Shares Purchased by Larson Financial Group LLC
news
few days ago at forbes.com         
Marina Von Neumann Whitman, Namer Of The Supply-Side Revolution
Usa forbes News
few days ago at zacks.com         
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
zacks News
few days ago at finance.yahoo.com         
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need T...
Yahoo News
six days ago at forbes.com         
Will 45 percent Of Work At Moderna Be Completed By AI By 2030 Yes
Usa forbes News
six days ago at finance.yahoo.com         
Parks Associates Announces Call for Papers for the Eighth Annual Future of Video Business of Streami...
Yahoo News
over a week ago at channelnewsasia.com         
Las Vegas Sands breaks ground on US8 billion expansion at Marina Bay Sands
news
over a week ago at prnewswire.com         
DISC Surgery Center at Marina del Rey Now In-Network with Medicare
prnewswire News
17 hours ago at finance.yahoo.com         
Exelixis Q2 Earnings Will Cabometyx Sales Drive Growth?
Yahoo News
2 days ago at www.macroaxis.com         
Disposition of 3706 shares by Stein Steven H of Incyte at 67.94 subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Hussman Strategic Advisors Inc. Boosts Holdings in Incyte Corporation
news
few days ago at thelincolnianonline.com         
Parcion Private Wealth LLC Purchases New Holdings in Incyte Corporation
news
six days ago at zacks.com         
INCY or TECH Which Is the Better Value Stock Right Now?
zacks News
over a week ago at gurufocus.com         
Incyte Price Target Adjusted by JPMorgan INCY Stock News
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
State of Michigan Retirement System Buys 200 Shares of Incyte Corporation
news
over a week ago at finance.yahoo.com         
William Blair Maintains Hold Rating on Incyte Corporation , Citing Future Revenue Uncertainties
Yahoo News
over two weeks ago at finance.yahoo.com         
Hope on the Horizon Cutting-Edge Therapies Redefine Outcomes in Glioblastoma Multiforme Treatment ma...
Yahoo News
over two weeks ago at thefly.com         
Disposition of 5935 shares by Iyengar Vijay K of Incyte at 68.15 subject to Rule 16b-3
news
17 hours ago at benzinga.com         
A Glimpse of West Pharmaceutical Servss Earnings Potential
benzinga news
2 days ago at finance.yahoo.com         
Kenya IVD Market Research Report 2025-2032 Opportunities in Increasing Adoption of Self-testing Kits...
Yahoo News
few days ago at thelincolnianonline.com         
Analysts Set Illumina, Inc. Price Target at 125.11
news
few days ago at benzinga.com         
Illumina Stock What Went Wrong And Why Its Best To Stay Away
benzinga news
over a week ago at finance.yahoo.com         
HRMY vs. ILMN Which Stock Should Value Investors Buy Now?
Yahoo News
over a week ago at thelincolnianonline.com         
Leavell Investment Management Inc. Raises Position in Illumina, Inc.
news
over a week ago at thefly.com         
Scotiabank gets more bearish on Illumina, downgrades shares ILMN
news
over a week ago at thefly.com         
Illumina just downgraded at Scotiabank, heres why ILMN
news
over a week ago at thefly.com         
CoreWeave initiated, Texas Instruments upgraded Wall Streets top analyst calls TXNTMOKLGCNKAMCILMNEX...
news
over a week ago at thelincolnianonline.com         
Illumina Given New 128.00 Price Target at Evercore ISI
news
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a minute ago at thelincolnianonline.com         
Silver Oak Securities Incorporated Boosts Holdings in AbbVie Inc.
news
a day ago at finance.yahoo.com         
AbbVie Outperforms Broader Market What You Need to Know
Yahoo News
2 days ago at finance.yahoo.com         
Chronic Plaque Psoriasis Market Analysis and Forecast Report 2025-2035 Personalized Medicine Fuels C...
Yahoo News
3 days ago at thelincolnianonline.com         
Montag A Associates Inc. Acquires 5,302 Shares of AbbVie Inc.
news
few days ago at thelincolnianonline.com         
Csenge Advisory Group Has 5.25 Million Stake in AbbVie Inc.
news
few days ago at insidermonkey.com         
Why AbbVie Remains a Dividend Standout in the Pharma Sector
insidermonkey News
few days ago at zacks.com         
AbbVie Inc. is Attracting Investor Attention Here is What You Should Know
zacks News
few days ago at thelincolnianonline.com         
Forum Financial Management LP Has 12.40 Million Stake in AbbVie Inc.
news
six days ago at zacks.com         
AbbVie Surpasses Market Returns Some Facts Worth Knowing
zacks News
a minute ago at statnews.com         
STAT Pharmalittle Were reading about legal battles over state PBM laws, Merck pulling an application...
news
17 hours ago at finance.yahoo.com         
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Tran...
Yahoo News
2 days ago at stockstory.org         
2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm
news
3 days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Shares Bought by Massachusetts Financial Services Co. MA
news
3 days ago at thelincolnianonline.com         
Teachers Retirement System of The State of Kentucky Increases Stock Holdings in Gilead Sciences, Inc...
news
few days ago at thelincolnianonline.com         
2,195 Shares in Gilead Sciences, Inc. Acquired by St. Louis Trust Co
news
few days ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc...
Macroaxis News: globenewswire.com
few days ago at gurufocus.com         
HOOKIPA Pharma Announces Delisting and Asset Sale Plan
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Gilead Sciences, Inc. is Bailard Inc.s 8th Largest Position
news
few days ago at stockgumshoe.com         
Midsummer Shorties from Doc Gumshoe
news
17 hours ago at thelincolnianonline.com         
Beacon Investment Advisory Services Inc. Has 220,000 Stock Holdings in Exact Sciences Corporation
news
few days ago at news.google.com         
Canaccord Genuity reiterates Buy rating on Exact Sciences stock ahead of study - Investing.com UK
Google News at Macroaxis
over a week ago at zacks.com         
Tempus AI Raises 2025 Financial Outlook Whats Backing It?
zacks News
over a week ago at gurufocus.com         
Exact Sciences Schedules Second Quarter 2025 Earnings Call EXAS Stock News
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Banque Pictet Cie SA Reduces Stock Position in Exact Sciences Corporation
news
over a week ago at finance.yahoo.com         
Exact Sciences Announces Medicare Coverage for Oncodetect Molecular Residual Disease Test in Colorec...
Yahoo News
over a week ago at thelincolnianonline.com         
Exact Sciences Corporation Receives Average Rating of Moderate Buy from Analysts
news
over two weeks ago at gurufocus.com         
Exact Sciences Target Price Raised by Evercore ISI Group EXAS Stock News
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
What Makes Exact Sciences a New Buy Stock
zacks News
over two weeks ago at simplywall.st         
One Exact Sciences Insider Raised Their Stake In The Previous Year
Simply Wall St News at Macroaxis
17 hours ago at globenewswire.com         
Stored Grain Insecticides Market, Industry Trends Growth Forecasts 2025-2030, with Profiles of Bayer...
Macroaxis News: globenewswire.com
3 days ago at thelincolnianonline.com         
Verdence Capital Advisors LLC Has 472,000 Holdings in Corteva, Inc.
news
few days ago at thefly.com         
Corteva price target raised by 14 at Argus, heres why CTVA
news
few days ago at finance.yahoo.com         
Cortevas Quarterly Earnings Preview What You Need to Know
Yahoo News
six days ago at zacks.com         
Corteva, Inc. Upgraded to Strong Buy What Does It Mean for the Stock?
zacks News
over a week ago at thefly.com         
Corteva price target raised by 12 at Oppenheimer, heres why CTVA
news
over a week ago at gurufocus.com         
Keybanc Analyst Raises Price Target for Corteva to 84 CTVA Stock News
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Northwest Capital Management Inc Has ,000 Holdings in Corteva, Inc.
news
over a week ago at thelincolnianonline.com         
Quotient Wealth Partners LLC Makes New 234,000 Investment in Corteva, Inc.
news
over a week ago at thefly.com         
Corteva price target raised by 11 at RBC Capital, heres why CTVA
news
17 hours ago at benzinga.com         
What Does the Market Think About BioMarin Pharmaceutical?
benzinga news
2 days ago at thelincolnianonline.com         
BioMarin Pharmaceutical Cut to Buy at Wall Street Zen
news
six days ago at finance.yahoo.com         
Wall Street Analysts Think BioMarin Could Surge 70.77 percent Read This Before Placing a Bet
Yahoo News
six days ago at zacks.com         
Wall Street Analysts Think BioMarin Could Surge 70.77 percent Read This Before Placing a Bet
zacks News
over a week ago at finance.yahoo.com         
Unpacking Q1 Earnings BioMarin Pharmaceutical In The Context Of Other Therapeutics Stocks
Yahoo News
over a week ago at thefly.com         
BioMarin price target raised by 5 at JPMorgan, heres why BMRN
news
over a week ago at gurufocus.com         
JP Morgan Raises Price Target for BioMarin Pharmaceutical to 113 BMRN Stock News
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
Yahoo News
over a week ago at insidermonkey.com         
BioMarin Pharmaceutical Finalizes the Acquisition of Inozyme Pharma
insidermonkey News
over a week ago at finance.yahoo.com         
Will BioMarin Beat Estimates Again in Its Next Earnings Report?
Yahoo News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
a day ago at finance.yahoo.com         
ROR Inhibitors Market Expected to Witness Significant Growth Through 2034 Due to the Rising Oncology...
Yahoo News
2 days ago at insidermonkey.com         
Biogen Inc. Partners with Stoke Therapeutics to Tackle Dravet Syndrome
insidermonkey News
few days ago at finance.yahoo.com         
Royalty Pharma Declares Third Quarter 2025 Dividend
Yahoo News
few days ago at thelincolnianonline.com         
Rachid Izzar Sells 2,223 Shares of Biogen Inc. Stock
news
few days ago at thelincolnianonline.com         
Whittier Trust Co. of Nevada Inc. Has 1.06 Million Stock Position in Biogen Inc.
news
six days ago at finance.yahoo.com         
The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry...
Yahoo News
over a week ago at thelincolnianonline.com         
Arizona State Retirement System Has 5.76 Million Position in Biogen Inc.
news
over a week ago at finance.yahoo.com         
Digital Biomarkers Market Size 2025 Expands with 22.74 percent CAGR with North America Leading at 59...
Yahoo News
over a week ago at thefly.com         
Biogen, Stoke Therapeutics present data from studies of zorevunersen BIIBSTOK
news
a minute ago at zacks.com         
Should JJ Stock Be in Your Portfolio After Q2 Beat Guidance Raise?
zacks News
17 hours ago at gurufocus.com         
Smead Value Funds Strategic Move Significant Addition of Diamondback Energy Inc
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate P...
Yahoo News
3 days ago at thelincolnianonline.com         
OneAscent Financial Services LLC Has 2.14 Million Stake in Amgen Inc.
news
3 days ago at thelincolnianonline.com         
Amgen Inc. Stake Boosted by Bingham Private Wealth LLC
news
few days ago at thelincolnianonline.com         
Kestra Private Wealth Services LLC Trims Stake in Amgen Inc.
news
few days ago at zacks.com         
Amgen Declines More Than Market Some Information for Investors
zacks News
few days ago at finance.yahoo.com         
Thyroid Gland Disorders Diagnostics and Treatment Market Analysis Report 2024-2030 Incorporation of ...
Yahoo News
few days ago at zacks.com         
Can Amgen Keep the Earnings Surprise Streak Alive?
zacks News
six days ago at finance.yahoo.com         
Earnings Preview What to Expect From Amgens Report
Yahoo News
There is far too much social signal, news, headlines, and media speculation about Biotechnology Fund that are available to investors today. This information is accessible both publicly - through Biotechnology Fund's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biotechnology-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biotechnology Fund news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biotechnology Fund relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biotechnology Fund's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biotechnology Fund alpha.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas